Management and Board Members
Dr. Amnon Gonenne, President, CEO and Director
Dr. Amnon Gonenne has more than 20 years experience in the biotechnology field in the U.S. and has held a number of top executive positions in regulatory affairs, supervision of international clinical trials, VP of Corporate Development (BioTechnology General Corp., NY) and CEO (Immunotherapy Inc., NY). He has led the successful registration and licensing of several genetically engineered products in the U.S. Between the years 2000-2002 he served as CEO of a VC fund (Elscint Biomedical Investment, Israel) which has made major investments in Gamida Cell Ltd. (Israel), a leading world class stem cell company.
Dr. Gonenne received his doctorate degree in Biochemistry and Biophysics from Syracuse University and completed his post-doctorate training at the University of California, San Diego Medical School.
Dr. Charles T. Tackney, Chief Scientific Officer
Dr. Tackney is a scientific and business leader with diverse experience in clinical medicine and new technology development, spanning the areas of molecular biology, biotechnology and diagnostics. Since 2009, Dr. Tackney has served as the Chief Scientific Officer at NeuroMark Genomics, Inc. Prior to that, he worked in various positions for the Ortho Clinical Diagnostics unit of Johnson & Johnson, including, Director of Diagnostic Biomarker Evaluation Group, Scientific Director of Advanced Research & Technology Assessment World Wide, and Director of Prion Research Group. Earlier in his career, Dr. Tackney served as the Director of the Department of Molecular Biology at ImClone Systems Inc., now a wholly-owned subsidiary of Eli Lilly.
Dr. Tackney earned his Ph.D. in molecular genetics from the City University of New York and was awarded a postdoctoral research fellowship from the Damon Runyon Foundation at Columbia University College of Physicians and Surgeons
Ron Kalfus, Chief Financial Officer
Mr. Kalfus serves as the Company's Chief Financial Officer, Treasurer and Secretary. Prior to joining MabCure, Mr. Kalfus held various positions at Toys "R" Us, Inc., both in the SEC Reporting department, responsible for the Company's financial reporting to the Securities and Exchange Commission, as well as in the Financial Planning & Analysis department, responsible for the Company's multi-billion dollar budgets. Prior to working at Toys "R" Us, Inc., Mr. Kalfus worked as an auditor for two large public accounting firms, specializing in audits of medium-sized enterprises as well as public companies.
Mr. Kalfus holds an MSc in Accounting from Fairleigh Dickinson University, and a BBA in Finance from the University of Georgia
Dr. David S. Frank, Director
Dr. Frank is the Managing Director of MEDx Associates, a consulting company in the field of diagnostics. He also serves as the Chairman of the Board of Nehora Photonics Ltd., a medical device company located in Israel. From 2007-2008, Dr. Frank served as a faculty member at the LAHAV-Tel Aviv University Graduate School of Business, where he taught “Health Care Technology” courses for bioscience entrepreneurs. From 1995-2007, Dr. Frank was the executive director of business development at Ortho-Clinical Diagnostics, a Johnson & Johnson company. From 1982-1994, Dr. Frank was the director of marketing and planning management at Kodak Clinical Diagnostics (Eastman Kodak Company).
Dr. Frank received his Ph.D. in biochemistry from Cornell University